The relationship between drug companies and jails

Jan 9, 2020
Incarcerated people form a large market for pharmaceutical companies. The ethics of that relationship can be complicated.
Tim Boyle/Getty Images

Companies reach $260 million deal to settle opioids lawsuit

Oct 21, 2019
The nation’s three dominant drug distributors and a big drugmaker have reached a $260 million deal to settle an opioid crisis lawsuit just as the first federal trial over the crisis was due to begin.
Pill Man, a skeleton made from Frank Huntley's oxycontin and methadone prescription bottles, is seen on Pennsylvania Avenue in front of the White House August 30, 2019, in Washington, DC.
BRENDAN SMIALOWSKI/AFP/Getty Images

Johnson & Johnson hit with $572 million opioid ruling — what happens now?

Johnson & Johnson is appealing the decision, which could be the first of many legal battles.
A judge has ordered Johnson & Johnson to pay $572 million in connection with the opioid crisis in Oklahoma.
Photo by Mario Tama/Getty Images

Another pharma megamerger: AbbVie buys Allergan for $63 billion

Jun 25, 2019
Both companies are under pressure to improve their performance.
PHILIPPE HUGUEN/AFP/Getty Images

Congress to examine drug price hikes

Jan 29, 2019
Prescription drug prices have been rising over the past few years.
jorgeantonio/iStock/Getty Images Plus

Who owns the results of genetic testing?

Oct 16, 2018
Personal data from genetic tests has been used in drug development and research.
A visitor views a digital representation of the human genome in 2001 at the American Museum of Natural History in New York City.
Mario Tama/Getty Images

Who owns the results of genetic testing?

Oct 16, 2018
Personal data from genetic tests has been used in drug development and research.
A visitor views a digital representation of the human genome in 2001 at the American Museum of Natural History in New York City.
Mario Tama/Getty Images

You’ve got questions. We help you answer them.

Support nonprofit, independent journalism that makes you smarter.

Generic Viagra floods the market. Here’s how Pfizer is reacting

Jul 13, 2018
Pfizer hopes to run with its “little blue pill” as long as it can. That includes the time-honored strategy of launching its own generic.
Christopher Furlong/Getty Images

In the midst of a massive opioid crisis, hospitals are experiencing an opioid shortage

May 14, 2018
Drug shortages are nothing new in U.S. hospitals.
Illustration by Emily Judem/WGBH News. Photos courtesy of Benjamin Pennell and Massachusetts General Hospital.
 
Justin Sullivan/Getty Images